• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, September 23, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

AI health coach lowers blood pressure and boosts engagement in patients with hypertension

Bioengineer by Bioengineer
May 29, 2024
in Health
Reading Time: 3 mins read
0
AI Health Coach Lowers Blood Pressure and Boosts Engagement in Patients With Hypertension
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

(Toronto, May 28, 2024) A new study in JMIR Cardio, published by JMIR Publications, shows that a fully digital, artificial intelligence (AI)–driven lifestyle coaching program can effectively reduce blood pressure (BP) in adults with hypertension. This AI-based program leverages data from wearable activity trackers and BP monitors as well as a mobile app questionnaire to tailor lifestyle guidance. The research team, led by Jared Leitner of the University of California, San Diego, used this innovative intervention to help manage hypertension and enhance patient engagement, offering a promising alternative to traditional coaching models.

AI Health Coach Lowers Blood Pressure and Boosts Engagement in Patients With Hypertension

Credit: Source: The authors / Adobe Stock; Copyright: The authors / onephoto; License: Licensed by JMIR Publications

(Toronto, May 28, 2024) A new study in JMIR Cardio, published by JMIR Publications, shows that a fully digital, artificial intelligence (AI)–driven lifestyle coaching program can effectively reduce blood pressure (BP) in adults with hypertension. This AI-based program leverages data from wearable activity trackers and BP monitors as well as a mobile app questionnaire to tailor lifestyle guidance. The research team, led by Jared Leitner of the University of California, San Diego, used this innovative intervention to help manage hypertension and enhance patient engagement, offering a promising alternative to traditional coaching models.

The researchers employed a single-arm nonrandomized trial to evaluate the effects of the program’s personalized lifestyle guidance, which was delivered to 141 participants through SMS text messages and a mobile app. Over 24 weeks, participants with stage 2 hypertension showed significant reductions in both systolic and diastolic BP. At 12 weeks, systolic BP decreased by an average of 9.6 mm Hg and diastolic BP by 5.7 mm Hg. These reductions were even more pronounced at 24 weeks, with systolic BP dropping by 14.2 mm Hg and diastolic BP by 8.1 mm Hg.

This precision coaching program led to an increase in participants achieving BP control and a decrease in participants with stage 2 hypertension. The study also highlighted high participant engagement and minimal need for manual clinician outreach. This indicates that the AI-driven approach not only enhances BP control but also substantially reduces the workload for health care providers.

“By pinpointing the top lifestyle contributors to patients’ hypertension and providing precise guidance, the AI-powered lifestyle coaching was able to maintain high patient engagement leading to improved patient outcomes. This study demonstrates how an AI-based, autonomous approach to hypertension-related lifestyle coaching can increase scalability and accessibility to effective blood pressure management,” remarked Dr. Leitner.

This research underscores the potential for digital health innovations to transform hypertension management, providing scalable, cost-effective, and personalized care options for patients.

Please cite as: 

Leitner J, Chiang PH, Agnihotri P, Dey S.

The Effect of an AI-Based, Autonomous, Digital Health Intervention Using Precise Lifestyle Guidance on Blood Pressure in Adults With Hypertension: Single-Arm Nonrandomized Trial.

JMIR Cardio 2024;8:e51916

URL: https://cardio.jmir.org/2024/1/e51916/

doi: 10.2196/51916

 

###

About JMIR Publications:
JMIR Publications is a renowned publisher with a long-standing commitment to advancing digital health research and progressing open science. Our portfolio includes a wide array of prestigious open access, peer-reviewed journals dedicated to the dissemination of high-quality research in the field of digital health. JMIR Publications is celebrating its 25th anniversary in 2024 as the leading open access, digital health publisher.

To learn more about JMIR Publications, please visit jmirpublications.com or connect with us via Twitter, LinkedIn, YouTube, Facebook, and Instagram.
Head office: 130 Queens Quay East, Unit 1100, Toronto, ON, M5A 0P6 Canada

Media contact: [email protected]

The content of this communication is licensed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, published by JMIR Publications, is properly cited.

 



Journal

JMIR Cardio

DOI

10.2196/51916

Subject of Research

People

Article Title

The Effect of an AI-Based, Autonomous, Digital Health Intervention Using Precise Lifestyle Guidance on Blood Pressure in Adults With Hypertension: Single-Arm Nonrandomized Trial

Article Publication Date

28-May-2024

COI Statement

JL, PHC, and SD are cofounders of CIPRA.ai Inc, a start-up company formed out of the University of California, San Diego, which has licensed the intervention technology presented in this paper. PA reports no conflict of interest.

Share12Tweet8Share2ShareShareShare2

Related Posts

How Federal Health Surveys Are Measuring Sexual Orientation, Gender Identity, and Differences in Sex Development

September 22, 2025

New CHART Guideline Outlines 12 Essential Reporting Items for AI Chatbot Health Advice Studies

September 22, 2025

Early-Career Family Physicians Face Burnout Linked to High Educational Debt and Extended Work Hours

September 22, 2025

Revolutionizing Lumbar Spine MRI with CNN Autoencoders

September 22, 2025

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    156 shares
    Share 62 Tweet 39
  • Physicists Develop Visible Time Crystal for the First Time

    69 shares
    Share 28 Tweet 17
  • Tailored Gene-Editing Technology Emerges as a Promising Treatment for Fatal Pediatric Diseases

    50 shares
    Share 20 Tweet 13
  • Scientists Achieve Ambient-Temperature Light-Induced Heterolytic Hydrogen Dissociation

    49 shares
    Share 20 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

How Federal Health Surveys Are Measuring Sexual Orientation, Gender Identity, and Differences in Sex Development

Gene Analysis Uncovers Metal Exposure in Synechococcus

New CHART Guideline Outlines 12 Essential Reporting Items for AI Chatbot Health Advice Studies

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.